ARCHIVES

FDA says new tools needed to speed therapeutics development.

This article is from The Cancer Letter archive.

Vol. 30 No. 13 | March 26, 2004

Download PDF Visit The Full Archive

Related Articles

Rev/Vel/Dex Response Rate High In Phase I/II Study

January 25, 2008

Bristol No Longer Needs Yew From Public Lands, Official Says; Will Use Processed Needles

January 29, 1993

NCI Director Klausner Resigns To Head Institute Begun By AOL Chairman Case.

September 14, 2001

Michael Friedman To Head PhRMA’s Office Of Biomedical Preparedness.

November 2, 2001

Blues Association, 2 cooperative Groups Form Pediatric Network

April 19, 1996

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014